Works matching IS 17921074 AND DT 2022 AND VI 24 AND IP 2


Results: 48
    1
    2
    3
    4
    5
    6
    7
    8

    Absolute lymphocyte count and C-reactive protein-albumin ratio can predict prognosis and adverse events in patients with recurrent esophageal cancer treated with nivolumab therapy.

    Published in:
    Oncology Letters, 2022, v. 24, n. 2, p. N.PAG, doi. 10.3892/ol.2022.13377
    By:
    • Inoue, Hiroyuki;
    • Shiozaki, Atsushi;
    • Fujiwara, Hitoshi;
    • Konishi, Hirotaka;
    • Kiuchi, Jun;
    • Ohashi, Takuma;
    • Shimizu, Hiroki;
    • Arita, Tomohiro;
    • Yamamoto, Yusuke;
    • Morimura, Ryo;
    • Kuriu, Yoshiaki;
    • Ikoma, Hisashi;
    • Kubota, Takeshi;
    • Okamoto, Kazuma;
    • Otsuji, Eigo
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48